Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
25.04 EUR | -1.49% | +0.48% | -32.31% |
May. 31 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
May. 31 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.31% | 1.82B | |
+48.55% | 55.7B | |
+38.82% | 39.91B | |
-6.72% | 39.57B | |
-6.65% | 28.16B | |
+13.04% | 26.3B | |
-21.83% | 18.94B | |
+29.02% | 12.17B | |
+25.97% | 12.12B | |
-0.49% | 12.12B |
- Stock Market
- Equities
- GLPG Stock
- News Galapagos NV
- Galapagos Partners with Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture